Natera Cancer Test Patents Upheld In Wake Of $19M Verdict
A Delaware federal judge on Tuesday upheld a pair of Natera Inc. patents covering cancer testing products, rejecting competitor ArcherDX's argument that Natera waited too long before filing for patents and...To view the full article, register now.
Already a subscriber? Click here to view full article